Anavex Life Sciences Corp (AVXL)

[falconer66a]

$$ First

The Science doesn't seem to break through until there is a guarantee of money associated with it.

Exactly.

The AVXL share price is controlled, totally affected by public perceptions of the company’s prospects to make money, not it’s science. Presently, the general share-buying public sees no possibility of revenues in any near-term period. Revenues, if any, are “way out there.” Generally, share-buying dollars are used to buy equities with rising price trend lines and/or dividends. Presently, Anavex Life Sciences Corp has neither.

Nonetheless, the underlying science of the Anavex molecules is extremely strong, revolutionary. The general share-buying public will not be able to connect that with anticipated corporate profits until, at least, the FDA or other national medical authority authorizes the sale of an Anavex drug. The solid science, to be proven in any of the three up-coming clinical trials of Anavex 2-73, will be affirmed. Then, Anavex Life Sciences Corp will be playing the share-trade game in the big leagues. The teams fielding drug players against Alzheimer’s will not be able to compete. Aricept will be sent back down to the minor leagues. Anavex 2-73 will wind every game it plays.

Check it all out, in, say 2023. That’s my hold ‘em AVXL time frame. Dead dollars now — but not then.